Active Ingredient Adalimumab

Active Ingredient Details

What is Adalimumab?

A humanized monoclonal antibody that binds specifically to TNF-ALPHA and blocks its interaction with endogenous TNF RECEPTORS to modulate INFLAMMATION. It is used in the treatment of RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS; CROHN'S DISEASE and ULCERATIVE COLITIS.

What is the usage for Adalimumab?

Adalimumab is used to reduce pain and swelling due to certain types of arthritis (such as rheumatoid, psoriatic, juvenile idiopathic, ankylosing spondylitis). This medication is also used to treat certain skin disorders (such as plaque-type psoriasis, hidradenitis suppurativa). It works by blocking a protein (tumor necrosis factor or TNF) found in the body's immune system that causes joint swelling and damage in arthritis as well as red scaly patches in psoriasis. Adalimumab belongs to a class of drugs known as TNF blockers. By reducing joint swelling, this medication helps to reduce further joint damage and preserve joint function. Adalimumab is also used to treat certain bowel conditions (Crohn's disease, ulcerative colitis) and a certain eye disease (uveitis).

How many products in the NDC database contain Adalimumab?

The NDC database has 58 products with the active ingredient Adalimumab. The following table lists all the products that have this active ingredient.

NDC Products with Adalimumab

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
0074-1115	Proprietary Name:	Adalimumab	Injection, Solution		Abbvie Inc.	ACTIVE
0074-1117	Proprietary Name:	Adalimumab	Injection, Solution		Abbvie Inc.	ACTIVE
0074-1867	Proprietary Name:	Adalimumab	Liquid		Abbvie Inc.	ACTIVE
0074-2330	Proprietary Name:	Adalimumab	Injection, Solution		Abbvie Inc.	ACTIVE
0078-1329	Proprietary Name:	Adalimumab-adaz	Liquid		Novartis Pharmaceuticals Corporation	ACTIVE
50090-6704	Proprietary Name: Hadlima	Adalimumab-bwwd	Solution	Subcutaneous	A-s Medication Solutions	ACTIVE
50090-6705	Proprietary Name: Hadlima	Adalimumab-bwwd	Solution	Subcutaneous	A-s Medication Solutions	ACTIVE
50090-6706	Proprietary Name: Hadlima	Adalimumab-bwwd	Solution	Subcutaneous	A-s Medication Solutions	ACTIVE
50090-6707	Proprietary Name: Hadlima	Adalimumab-bwwd	Solution	Subcutaneous	A-s Medication Solutions	ACTIVE
55513-399	Proprietary Name: Amjevita	Adalimumab-atto	Injection	Subcutaneous	Amgen Inc	ACTIVE
55513-400	Proprietary Name: Amjevita	Adalimumab-atto	Injection	Subcutaneous	Amgen Inc	ACTIVE
55513-410	Proprietary Name: Amjevita	Adalimumab-atto	Injection	Subcutaneous	Amgen Inc	ACTIVE
55513-411	Proprietary Name: Amjevita	Adalimumab-atto	Injection	Subcutaneous	Amgen Inc	ACTIVE
55513-413	Proprietary Name: Amjevita	Adalimumab-atto	Injection	Subcutaneous	Amgen Inc	ACTIVE
55513-479	Proprietary Name: Amjevita	Adalimumab-atto	Injection	Subcutaneous	Amgen Inc	ACTIVE
55513-480	Proprietary Name: Amjevita	Adalimumab-atto	Injection	Subcutaneous	Amgen Inc	ACTIVE
55513-481	Proprietary Name: Amjevita	Adalimumab-atto	Injection	Subcutaneous	Amgen Inc	ACTIVE
55513-482	Proprietary Name: Amjevita	Adalimumab-atto	Injection	Subcutaneous	Amgen Inc	ACTIVE
58394-051	Proprietary Name:	Adalimumab	Liquid		Wyeth Biopharma Division Of Wyeth Pharmaceuticals Llc	ACTIVE
61314-325	Proprietary Name: Adalimumab	Adalimumab-adaz	Injection, Solution	Subcutaneous	Sandoz Inc	ACTIVE
61314-327	Proprietary Name: Adalimumab	Adalimumab-adaz	Injection, Solution	Subcutaneous	Sandoz Inc	ACTIVE
61314-332	Proprietary Name: Adalimumab	Adalimumab-adaz	Injection, Solution	Subcutaneous	Sandoz Inc	ACTIVE
61314-391	Proprietary Name: Adalimumab	Adalimumab-adaz	Injection, Solution	Subcutaneous	Sandoz Inc	ACTIVE
61314-454	Proprietary Name: Hyrimoz	Adalimumab-adaz	Injection, Solution	Subcutaneous	Sandoz Inc	ACTIVE
61314-473	Proprietary Name: Hyrimoz	Adalimumab-adaz	Injection, Solution	Subcutaneous	Sandoz Inc	ACTIVE
61314-476	Proprietary Name: Hyrimoz	Adalimumab-adaz	Injection, Solution	Subcutaneous	Sandoz Inc	ACTIVE
61314-509	Proprietary Name: Hyrimoz	Adalimumab-adaz	Injection, Solution	Subcutaneous	Sandoz Inc	ACTIVE
70114-210	Proprietary Name: Yusimry	Adalimumab-aqvh	Injection, Solution	Subcutaneous	Coherus Biosciences Inc	ACTIVE
70114-220	Proprietary Name: Yusimry	Adalimumab-aqvh	Injection, Solution	Subcutaneous	Coherus Biosciences Inc	ACTIVE
71124-0023	Proprietary Name:	Adalimumab	Liquid		Samsung Biologics Co., Ltd.	ACTIVE
71124-0027	Proprietary Name:	Adalimumab	Liquid		Samsung Biologics Co., Ltd.	ACTIVE
71288-815	Proprietary Name: Yusimry	Adalimumab-aqvh	Injection, Solution	Subcutaneous	Meitheal Pharmaceuticals Inc.	ACTIVE
71288-816	Proprietary Name: Yusimry	Adalimumab-aqvh	Injection, Solution	Subcutaneous	Meitheal Pharmaceuticals Inc.	ACTIVE
72511-399	Proprietary Name: Amjevita	Adalimumab-atto	Injection	Subcutaneous	Amgen Usa Inc.	ACTIVE
72511-400	Proprietary Name: Amjevita	Adalimumab-atto	Injection	Subcutaneous	Amgen Usa Inc.	ACTIVE
72511-479	Proprietary Name: Amjevita	Adalimumab-atto	Injection	Subcutaneous	Amgen Usa Inc.	ACTIVE
72511-481	Proprietary Name: Amjevita	Adalimumab-atto	Injection	Subcutaneous	Amgen Usa Inc.	ACTIVE
72511-482	Proprietary Name: Amjevita	Adalimumab-atto	Injection	Subcutaneous	Amgen Usa Inc.	ACTIVE
78206-183	Proprietary Name: Hadlima	Adalimumab-bwwd	Solution	Subcutaneous	Organon Llc	ACTIVE
78206-184	Proprietary Name: Hadlima	Adalimumab-bwwd	Solution	Subcutaneous	Organon Llc	ACTIVE
78206-185	Proprietary Name: Hadlima	Adalimumab-bwwd	Solution	Subcutaneous	Organon Llc	ACTIVE
78206-186	Proprietary Name: Hadlima	Adalimumab-bwwd	Solution	Subcutaneous	Organon Llc	ACTIVE
78206-187	Proprietary Name: Hadlima	Adalimumab-bwwd	Solution	Subcutaneous	Organon Llc	ACTIVE
83012-035	Proprietary Name:	Cyltezo	Liquid		Boehringer Ingelheim Fremont, Inc.	ACTIVE
83012-036	Proprietary Name:	Cyltezo	Liquid		Boehringer Ingelheim Fremont, Inc.	ACTIVE
83012-037	Proprietary Name:	Cyltezo	Liquid		Boehringer Ingelheim Fremont, Inc.	ACTIVE
83012-038	Proprietary Name:	Cyltezo	Liquid		Boehringer Ingelheim Fremont, Inc.	ACTIVE
83457-100	Proprietary Name: Hyrimoz	Adalimumab-adaz	Injection, Solution	Subcutaneous	Cordavis Limited	ACTIVE
83457-101	Proprietary Name: Hyrimoz	Adalimumab-adaz	Injection, Solution	Subcutaneous	Cordavis Limited	ACTIVE
83457-102	Proprietary Name: Hyrimoz	Adalimumab-adaz	Injection, Solution	Subcutaneous	Cordavis Limited	ACTIVE
83457-103	Proprietary Name: Hyrimoz	Adalimumab-adaz	Injection, Solution	Subcutaneous	Cordavis Limited	ACTIVE
83457-107	Proprietary Name: Hyrimoz	Adalimumab-adaz	Injection, Solution	Subcutaneous	Cordavis Limited	ACTIVE
83457-108	Proprietary Name: Hyrimoz	Adalimumab-adaz	Injection, Solution	Subcutaneous	Cordavis Limited	ACTIVE
83457-113	Proprietary Name: Hyrimoz	Adalimumab-adaz	Injection, Solution	Subcutaneous	Cordavis Limited	ACTIVE
84612-399	Proprietary Name: Amjevita	Adalimumab-atto	Injection	Subcutaneous	Optum Health Solutions (ireland) Limited	ACTIVE
84612-479	Proprietary Name: Amjevita	Adalimumab-atto	Injection	Subcutaneous	Optum Health Solutions (ireland) Limited	ACTIVE
84612-481	Proprietary Name: Amjevita	Adalimumab-atto	Injection	Subcutaneous	Optum Health Solutions (ireland) Limited	ACTIVE
84612-482	Proprietary Name: Amjevita	Adalimumab-atto	Injection	Subcutaneous	Optum Health Solutions (ireland) Limited	ACTIVE